Barclays Maintains Overweight on MasTec, Lowers Price Target to $120
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Adam Seiden maintains an Overweight rating on MasTec (NYSE:MTZ) but lowers the price target from $135 to $120.
August 07, 2023 | 2:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays maintains an Overweight rating on MasTec but lowers the price target from $135 to $120.
The news is directly related to MasTec (MTZ). Barclays' decision to maintain an Overweight rating indicates a positive outlook for the company. However, the lowering of the price target from $135 to $120 might create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100